跳至主要内容
临床试验/NCT00933764
NCT00933764撤回不适用

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR)

Abbott RDx Cardiometabolic2 个研究点 分布在 1 个国家开始时间: 2009年8月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
2

研究概览

简要总结

This is a multi-center study designed to assess the accuracy and precision of the Cholestech LDX Cardiac hsCRP test for the quantitative determination of C-reactive protein (CRP) in whole blood, serum and plasma from individuals being assessed for risk of cardiovascular disease. The Cholestech LDX Cardiac hsCRP test consists of the CRP cassette and LDX analyzer and measures CRP with high sensitivity on fingerstick or venous whole blood at the point-of-care (POC). The results of this study are intended to be used for regulatory 510k filings for use as an in vitro diagnostic test.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults (18 years of age or older) presenting to their physician's office or outpatient clinic for routine or pre-scheduled visits and a candidate for cardiovascular risk assessment.
  • •Willing and able to provide written informed consent and comply with study procedures.

排除标准

  • •Known hematocrit <30% or > 52%;
  • •History of medical conditions - other than risk of cardiovascular disease - that may elevate CRP as listed in Appendix B (e.g., tissue damage, infection, inflammation, malignant neoplasia)
  • •Vulnerable populations deemed inappropriate for study by the site's principal investigator.

研究者

发起方
Abbott RDx Cardiometabolic
申办方类型
Other

研究点 (2)

Loading locations...

相似试验